Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration

Clinical trial NCT00239928 · COMPLETED

Trial details

NCT number: NCT00239928
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Macular Degeneration

Start date: 2005-09-01
Primary completion: 2008-11-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.